Literature DB >> 15117237

Tissue CA-19.9 content in colorectal adenomas and its value in the assessment of dysplasia.

I Salces1, I Vegh, S Rodríguez-Muñoz, F Colina, A Pérez, S Soto, F Sánchez, J de la Cruz, J A Solís-Herruzo.   

Abstract

BACKGROUND: occasionally, the risk of malignant transformation may be difficult to establish in adenomatous polyps due to the fact that they contain areas with variable grades of dysplasia. A measurement of tissue tumor markers may be useful to recognize these adenomas.
OBJECTIVES: the aims of this study were: to established firstly the relationship between carbohydrate antigen 19.9 (CA-19.9) content in the colorectal mucosa and the characteristics of polyps, and secondly, the diagnostic value of the formers measurement. PATIENTS AND METHODS: tissue CA-19.9 concentration was measured in 155 colorectal samples obtained from 145 patients (21 normal mucosa; 113 adenomatous polyps; 21 adenocarcinoma). Cytosol CA-19.9 content was determined by enzyme-linked immunoadsorbant assay, and the measurement of this protein was achieved by quantitative assay. Tissue samples were also processed for histological examination.
RESULTS: we demonstrated that CA-19.9 levels in adenomatous polyps and adenocarcinomas were significantly higher than in the normal mucosa. These levels varied significantly according to polyp size, histological type, and grade of dysplasia. CA-19.9 contents were higher in polyps with a high risk of malignant transformation than in those with a low risk of severe dysplasia. The cut-off value 214 U/mg of protein properly differentiated both types of risk. The area under the receiver operating characteristic (ROC) curves showed that cytosol CA-19.9 levels allow classifying polyps according to their histological features.
CONCLUSIONS: we concluded that the measurement of CA-19.9 content in adenomatous polyps may be useful to classify these tumors and confirm the feasibility to separate adenomas into two groups: low and high risk of malignant change.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117237     DOI: 10.4321/s1130-01082004000400003

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  3 in total

1.  Elevated carbohydrate antigen 19-9 caused by early colon cancer treated with endoscopic mucosal resection.

Authors:  Hajime Aoyama; Yuji Tobaru; Ryosaku Tomiyama; Kiyoshi Maeda; Kazuto Kishimoto; Tetsuo Hirata; Akira Hokama; Fukunori Kinjo; Jiro Fujita
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

2.  In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy.

Authors:  Louis-Bastien Weiswald; Jean-Marc Guinebretière; Sophie Richon; Dominique Bellet; Bruno Saubaméa; Virginie Dangles-Marie
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

3.  Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.

Authors:  Nam Hee Kim; Mi Yeon Lee; Jung Ho Park; Dong Il Park; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Yonsei Med J       Date:  2017-09       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.